Success Metrics

Clinical Success Rate

100.0%

Based on 1 completed trials

Completion Rate

100%(1/1)

Active Trials

1(25%)

Results Posted

0%(0 trials)

Phase Distribution

Ph not_applicable

100%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution4 total trials

N/ANon-phased studies

4(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(2)

Completed(1)

Other(1)

Detailed Status

Completed1

unknown1

Not yet recruiting1

Recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

N/A

Trials by Phase

N/A4 (100.0%)

Trials by Status

completed125%

unknown125%

not_yet_recruiting125%

recruiting125%

Recent Activity

1 active trials

Showing 4 of 4

not_yet_recruitingnot_applicable

Efficacy of Remote Ischemic Conditioning in Preventing Post-Stroke Depression

NCT06920706

recruitingnot_applicable

Remote Ischemic Conditioning for Cerebral Ischemia in Patients With Takayasu Arteritis (TARIC-1)

NCT06178419

completednot_applicable

Protective Effects of RIC in Elderly With Acute Ischemic Stroke Complicating Acute Coronary Syndrome

NCT03868007

unknownnot_applicable

Remote Ischemic Conditioning for the Treatment of Resistant Hypertension

NCT05426707

Clinical Trials (4)

Showing 4 of 4 trials

NCT06920706Not Applicable

Efficacy of Remote Ischemic Conditioning in Preventing Post-Stroke Depression

Not Yet Recruiting

NCT06178419Not Applicable

Remote Ischemic Conditioning for Cerebral Ischemia in Patients With Takayasu Arteritis (TARIC-1)

Recruiting

NCT03868007Not Applicable

Protective Effects of RIC in Elderly With Acute Ischemic Stroke Complicating Acute Coronary Syndrome

Completed

NCT05426707Not Applicable

Remote Ischemic Conditioning for the Treatment of Resistant Hypertension

Unknown

All 4 trials loaded

Drug Details

Intervention Type: DEVICE
Total Trials: 4